Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical Cord Blood Natural Killer (NK) Cell Therapy

Umbilical cord blood-derived natural killer cells · Sun Yat-sen University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical Cord Blood Natural Killer (NK) Cell Therapy, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma. [Phase 1]

See pricing